|
Market Closed -
Canadian Securities Exchange
14:31:18 21/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -83.33% |
| Market Cap | 1.19M 867K 743K 695K 636K 82.96M 1.21M 8.21M 3.2M 41.68M 3.26M 3.18M 138M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 342K 293K 274K 251K 32.69M 477K 3.24M 1.26M 16.42M 1.28M 1.25M 54.31M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 3 months | -33.33% | ||
| 6 months | -50.00% | ||
| Current year | -83.33% |
| 1 week | 0.01 | 0.01 | |
| 1 month | 0.01 | 0.01 | |
| Current year | 0 | 0.05 | |
| 1 year | 0 | 0.25 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 0.75 | |
| 10 years | 0 | 1.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 30/09/2019 |
José Roldan
DFI | Director of Finance/CFO | - | 08/12/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 30/09/2019 |
Daniel Augereau
BRD | Director/Board Member | 82 | 30/09/2019 |
Eric Klein
BRD | Director/Board Member | 66 | 30/09/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02/06/25 | Sell | Chief Executive Officer | 4,667,000 | 3.9091% | ||
| 21/03/25 | Buy | Chief Executive Officer | 200,000 | 0.1675% | ||
| 21/03/25 | Buy | Chief Executive Officer | 100,000 | 0.0838% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | -80.00% | 867K | ||
| +0.88% | +6.38% | +76.86% | +128.23% | 1,119B | ||
| +1.07% | +3.80% | +51.03% | +61.48% | 651B | ||
| +1.20% | +6.21% | +26.47% | +76.45% | 468B | ||
| +1.02% | +5.77% | +43.09% | +47.70% | 374B | ||
| +0.85% | +4.07% | +23.88% | +41.58% | 302B | ||
| +1.26% | +6.81% | +1.59% | +14.67% | 259B | ||
| +1.88% | +5.81% | +48.54% | +68.52% | 238B | ||
| +1.59% | +2.09% | -15.52% | -52.29% | 208B | ||
| +1.87% | +5.61% | +25.81% | +92.42% | 181B | ||
| Average | +1.16% | +4.48% | +28.18% | +39.88% | 379.99B | |
| Weighted average by Cap. | +1.14% | +5.09% | +44.31% | +72.55% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.15M 2.7M 2.53M 2.31M 302M 4.4M 29.86M 11.64M 152M 11.84M 11.58M 501M | 3.36M 2.44M 2.09M 1.96M 1.79M 234M 3.41M 23.11M 9.01M 117M 9.16M 8.97M 388M |
| Net income | -16.5M -11.98M -10.27M -9.61M -8.79M -1.15B -16.72M -113M -44.26M -576M -45M -44.02M -1.91B | -8.91M -6.47M -5.54M -5.19M -4.75M -619M -9.03M -61.28M -23.9M -311M -24.3M -23.77M -1.03B |
| Net Debt | -626K -454K -389K -364K -333K -43.48M -634K -4.3M -1.68M -21.84M -1.71M -1.67M -72.25M | -723K -525K -450K -421K -386K -50.27M -733K -4.98M -1.94M -25.25M -1.97M -1.93M -83.53M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | CA$0.0100 | 0.00% | 1,000 |
- Stock Market
- Stocks
- RAMM Stock
Select your edition
All financial news and data tailored to specific country editions
















